Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congress Can Find Consensus On Drug Pricing By Targeting Cost Drivers – Waxman

Executive Summary

Former Rep. Henry Waxman, D-Cal., discusses prospects for legislation on drug pricing, suggesting President Trump's comments on issue provide Congress an 'opportunity' to pursue change.

You may also be interested in...



Fight Brewing In Congress Over Part D Coverage Gap Discounts

At Cross-Purposes? How Trump Budget's Part D Gap Discount Policy Aligns With New Law

President Trump's 2019 federal budget proposal includes plan to exclude manufacturer discounts in the Medicare Part D coverage gap from beneficiaries' out-of-pocket totals, which may be at odds with recently enacted legislation.

Generic Savings: REMS Obstruction, Not ANDA Backlog, Is Main Hindrance, AAM Says

Association for Accessible Medicines report highlights continuing upward trend of cost savings from generic drugs; trade group argues legislative proposals addressing restricted distribution misuse are key to accelerating savings.

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel